INFORMATION FOR
News
Dr. Jeffrey Townsend on Yale Cancer Answers.
A new open-source software package called cancereffectsizeR developed by the Townsend Lab greatly improves the ability of data scientists and clinical analysts to pinpoint specific genetic mutations that drive cancer.
This Department of Defense award goes to the “best and brightest in their fields,” and recognizes “creative and innovative individuals.” Investigators are chosen for their ability “to go beyond conventional thinking” in their respective areas of expertise.
A podcast from The Naked Scientists about cancer immunotherapy research at Yale School of Medicine
Cancer cells are masters at avoiding detection, but a new system developed by Yale Cancer Center scientists can make them stand out from the crowd and help the immune system spot and eliminate tumors that other forms of immunotherapies might miss, the researchers report Oct. 14 in the journal Nature Immunology.
In a new study, researchers at Yale have created a new method to detect metastasis, or the spread of cancer, by identifying the genetic interactions between cells.
The ability of cancer to establish itself in distant parts of the body — called metastasis — causes 90% of deaths from solid tumors. Metastasis is the result of complex genetic interactions that have proven difficult for scientists to study. Now Yale researchers have devised a way to identify some of the most dangerous of those interactions.
Scientists at the Yale Systems Biology Institute have taken a step closer to understanding how the genetic makeup of cancer cells directs the formation of a cancer and influences the tumor microenvironment.
Yale researchers have developed a new way to efficiently engineer immune cells, an advance which enhances the ability to fend off cancer and other diseases, they report in the Feb. 25 issue of the journal Nature Methods.
Researchers at the Yale School of Public Health have discovered a mathematical relationship that sheds new light on the rate at which cancer cells mutate and why some survive and rapidly multiply, yet others do not.
Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes.
A recent study conducted by scientists at Yale Cancer Center demonstrates that spatial gene signatures can significantly enhance the prediction of immunotherapy outcomes in patients with melanoma.
Pennsylvania families worry about rising cases of rare cancer with fracking well pads near their homes and stalled House bills. YSPH Associate Professor Nicole Deziel shares her insights.
Profiles in Survivorship: Craig Studer
Dr. Vasilis Vasiliou on Yale Cancer Answers.
Learn three main areas of research within Yale Urology and what motivates the faculty behind it.
Stephen, 61, traveled over 5,000 from Hawaii to Yale to have Dr. Jennifer Moliterno perform brain surgery. Dr. Moliterno performs more brain surgeries than any other physician in Connecticut, and patients like Stephen travel long distances due to her experience and efficiency.
In an interview, Rachel Perry, PhD, discusses the link between insulin and cancer, a surprising finding in her research, and the future of precision medicine for metabolism-related cancers.
A mouth rinse used to identify oral microbiome composition could serve as an early-detection tool for gastric cancer, new evidence suggests.
Amos S. Espinosa, a PhD Candidate in Experimental Pathology, was recently named a winner of the American Society of Hematology's Minority Hematology Graduate Award.